Published Date: 10 Mar 2023
Nearly two dozen clinical trials targeting the immune system are in clinical trials for Alzheimer's disease.
Read Full NewsThird molar removal may improve oral health markers, but its benefits must be weighed against surgical risks, postoperative morbidity, and cost.
Stopping aspirin early in dual antiplatelet therapy is tied to a lower risk for bleeding with no increase in ischemic risks after coronary stenting, a new meta-analysis finds.
The World Health Organization on Thursday declared the hantavirus outbreak linked to a cruise ship over after the last identified contact of an exposed person completed...
New South Wales became Australia's third state to confirm a case of H5N1 bird flu after authorities said a migratory seabird found near a coastal town returned a positive...
The $500 million seed fund will support universal antiviral platforms and air cleaning technologies.
New study finds nearly 10% of internal medicine residents report a disability; the American Medical Association updates maternity care billing codes; and Texas joins autism trial network.
A phase 3 trial compares first-line fixed-duration venetoclax-obinutuzumab to fludarabine, cyclophosphamide, and rituximab/bendamustine-rituximab in patients with CLL.
1.
Life quality after childhood cancer is quantifiable thanks to outcome indicators.
2.
Doctor Suspected of Murder; Cancer Blood Test Under Fire; TikTok and Body Image
3.
Men With Prostate Cancer Experience Less Hot Flashes When Using an Affordable Drug.
4.
Annual whole-body, low-dose CT aids management of smoldering multiple myeloma
5.
examining differences in the rates of breast reconstruction following mastectomies.
1.
Importance of Early Detection in Oncology
2.
Tumor Ecosystem Modulation in Precision Oncology
3.
Unlocking the Power of Hematocrit: Exploring the Benefits of Blood Cell Counts
4.
Trends in Incidence, Care, and Surgery for Medullary Thyroid Cancer: A Review
5.
The importance of understanding normal serum osmolality
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Rates of CR/CRi and MRD Negativity in Iontuzumab-Treated Patients
2.
CNS Clarity from Day One: Rethinking Early Diagnostic Strategies in ALK+NSCLC
3.
Navigating the Complexities of Ph Negative ALL - Part IV
4.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II
5.
Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation